Wuzhou Medical’s Flat Stock Signals Deep Margin Decline and Stagnant Growth
Wuzhou Medical faces a stark mid‑year slump—flat stock, shrinking margins, and a 70% Q3 profit plunge—highlighting urgent liquidity and strategy challenges amid fierce industry competition.
3 minutes to read

